We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.56B
AUM Growth
-$38.5M
Cap. Flow
-$387M
Cap. Flow %
-24.76%
Top 10 Hldgs %
13.79%
Holding
357
New
58
Increased
94
Reduced
104
Closed
53

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$15.9M
2
AVGO icon
Broadcom
AVGO
+$7.71M
3
FCAM
Fiat Chrysler Automobiles N.V.
FCAM
+$7.55M
4
VC icon
Visteon
VC
+$6.62M
5
MGM icon
MGM Resorts International
MGM
+$6.53M

Top Sells

Rank Stock Value
1
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$13.6M
2
VEEV icon
Veeva Systems
VEEV
+$9.49M
3
ALL icon
Allstate
ALL
+$9.41M
4
PAY
Verifone Systems Inc
PAY
+$8.26M
5
URI icon
United Rentals
URI
+$6.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.11%
2 Healthcare 12.19%
3 Technology 11.28%
4 Financials 9.06%
5 Industrials 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZD icon
126
Ziff Davis
ZD
$2.04B
$3.74M 0.24%
+63,333
New +$3.75M
XLNX
127
DELISTED
Xilinx Inc
XLNX
$3.74M 0.24%
+84,607
New +$3.81M
WIX icon
128
WIX.com
WIX
$2.7B
$3.73M 0.24%
158,069
-38,054
-19% -$866K
LOGM
129
DELISTED
LogMein, Inc.
LOGM
$3.71M 0.24%
57,552
-31,427
-35% -$1.97M
SKX
130
DELISTED
Skechers
SKX
$3.71M 0.24%
101,370
-57,927
-36% -$1.86M
ABMD
131
DELISTED
Abiomed Inc
ABMD
$3.67M 0.24%
55,847
+32,068
+135% +$2.13M
ICPT
132
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.67M 0.24%
15,202
-1,994
-12% -$531K
SCS
133
DELISTED
Steelcase
SCS
$3.65M 0.23%
193,036
-61,854
-24% -$1.13M
HII icon
134
Huntington Ingalls Industries
HII
$12.5B
$3.64M 0.23%
32,312
-4,342
-12% -$552K
PCTY icon
135
Paylocity
PCTY
$8.18B
$3.6M 0.23%
100,392
-34,599
-26% -$1.11M
LQ
136
DELISTED
La Quinta Holdings Inc.
LQ
$3.57M 0.23%
156,069
+53,730
+53% +$1.28M
BERY
137
DELISTED
Berry Global Group, Inc.
BERY
$3.56M 0.23%
119,790
+11,537
+11% +$363K
CRTO icon
138
Criteo S.A. Ordinary Shares
CRTO
$857M
$3.56M 0.23%
74,662
-17,395
-19% -$793K
TTPH
139
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$3.53M 0.23%
3,725
-1,195
-24% -$977K
CORE
140
DELISTED
Core Mark Holding Co., Inc.
CORE
$3.5M 0.22%
118,282
-37,924
-24% -$1.07M
TMH
141
DELISTED
Team Health Holdings Inc
TMH
$3.47M 0.22%
53,159
-17,120
-24% -$1.03M
SPWR
142
DELISTED
SunPower Corporation Common Stock
SPWR
$3.46M 0.22%
186,256
+46,972
+34% +$987K
ALEX
143
DELISTED
Alexander & Baldwin
ALEX
$3.44M 0.22%
87,171
-20,213
-19% -$831K
SNBR
144
DELISTED
Sleep Number
SNBR
$3.42M 0.22%
113,882
+7,168
+7% +$227K
CONE
145
DELISTED
CyrusOne Inc Common Stock
CONE
$3.41M 0.22%
115,843
-8,268
-7% -$258K
ZBH icon
146
Zimmer Biomet
ZBH
$19B
$3.39M 0.22%
31,942
+459
+1% +$50.8K
AAC
147
DELISTED
AAC Holdings
AAC
$3.35M 0.21%
+76,844
New +$2.83M
AIG icon
148
American International
AIG
$42.1B
$3.34M 0.21%
+54,047
New +$3.19M
ACAT
149
DELISTED
Arctic Cat Inc
ACAT
$3.34M 0.21%
100,562
-32,239
-24% -$1.12M
AMT.PRA
150
DELISTED
American Tower Corporation
AMT.PRA
$3.32M 0.21%
32,595
-3,280
-9% -$340K
4 5
6
7 8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Nicholas Investment Partners held 357 positions worth $1.56B, down 2.4% from $1.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Nicholas Investment Partners withdrew a net $387M in Q2 2015, closing 53 positions and reducing 104 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nicholas Investment Partners opened a new position in Allergan plc worth $15.9M.

  • Nicholas Investment Partners's largest Q2 2015 buy was Allergan plc: 15,220 shares worth $15.9M.
  • Nicholas Investment Partners added most to Visteon in Q2 2015, an estimated $6.62M increase.
  • Nicholas Investment Partners's biggest Q2 2015 reduction was Illumina, cutting an estimated $6.06M.
  • Nicholas Investment Partners fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $13.6M.
  • Nicholas Investment Partners's ten largest holdings make up 14% of its $1.56B portfolio in Q2 2015.
  • Nicholas Investment Partners opened 58 new positions and closed 53 in Q2 2015.
  • Nicholas Investment Partners's portfolio value fell 2.4% quarter-over-quarter to $1.56B.

Based on Nicholas Investment Partners's 13F filing for Q2 2015, filed 17 Aug 2015.